A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Agonists of TREM2
What It Covers This patent protects antibodies that act as agonists of TREM2 (Triggering Receptor Expressed on Myeloid Cells 2) — i.e., engineered antibodies that specifically bind to and activate the TREM2 receptor on immune…
-
Semaglutide in Medical Therapy
What This Patent Covers This patent protects the use of semaglutide — a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist — in specific medical therapy applications. Semaglutide is a cornerstone molecule for Novo Nordisk’s blockbuster drugs:…
-
Targeted Expression of Regeneration Factors in Aged/Senescent Cells
Publication: WO2025/208002 (international patent application filed by Altos Labs, Inc.) What the Patent Covers This patent application focuses on methods and materials for selectively expressing regeneration factors specifically in aged or senescent cells—the cells that…
BioTech IP Review 